RH CAPITAL ANNOUNCES THREE NEW INVESTMENTS TO IMPROVE WOMEN'S HEALTH

SAN FRANCISO, June 2, 2022 /PRNewswire/ -- Today, RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US. Investing from its second fund that will hold its final close in June, RH Capital focuses on improving access, affordability, choice, and health outcomes for women in the US and beyond. Recent investments in Cayaba Care, Cirqle Biomedical, and Planerabring the fund's current portfolio to twelve companies.

"With the impending SCOTUS decision to repeal Roev. Wade, there is even more urgency to ensure women have access to contraception and quality maternal health care," said Elizabeth Bailey, Managing Director of RH Capital. "It has always been our position that reproductive and maternal care are essential health care. Now, the private sector - and startups in particular - will have an even greater role in ensuring health equity for women."

Led by Seae Venturesand Kapor Capital, RH Capital joined a $12 million Series A financing for Cayaba Care, which provides comprehensive and holistic maternity services to underserved communities, helping to address health inequities in the US for BIPOC and low-income populations.

RH Capital also invested in Cirqle Biomedical, a Danish-based company developing an effective, non-hormonal contraceptive that meets the needs of women looking to avoid the side effects of hormonal methods. "We are thrilled to partner with RH Capital, with its deep domain expertise in contraceptive innovation and women's health. Their support will help us bring to market a new and needed contraceptive offering for women around the world," mentioned CEO Frederik PeturssonMadsen.

RH Capital also closed an investment in Planera's $9.5 million Seed round, led by Valo Ventures. Planera is developing the first certified flushable and 100% biodegradable menstrual pad, addressing environmental concerns regarding microplastics, adhesives, and other chemicals which contribute to over three million tons of waste per year.

"RH Capital is proud to partner with Cayaba, Cirqle, Planera, and all of our portfolio companies that share our commitment to ushering in the next generation of innovations that will improve the health and wellbeing of women in the US," added Stasia Obremskey, Managing Director.

RH Capital, a Rhia Ventures fund, is an impact venture capital fund that invests in early-stage startups that promise to revolutionize women's health and improve health equity in the US.  Its primary focus areas include contraception and maternal health while investing in other high-impact and underinvested areas such as fibroids, PCOS, STIs, endometriosis, pelvic health, menopause, etc.  RH Capital invests across all healthcare segments, including the life sciences (diagnostics, devices, therapeutics), digital health, consumer products, and health services.

Contact: [email protected] , 626.257.8991

SOURCE RH Capital